Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.
The expertise of specialized pharmacists enables them to circumvent insurance barriers, improve adherence rates, and contribute to healthcare cost savings.
Researchers suggest that measures aimed at improving mood could reduce inflammation and potentially provide an alternative treatment or one that works alongside inflammatory bowel disease medications.